サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1498750

シングルドメイン抗体プラットフォーム市場：プラットフォームタイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Single Domain Antibody Platforms Market, By Platform Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 270 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
シングルドメイン抗体プラットフォーム市場：プラットフォームタイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 270 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

シングルドメイン抗体プラットフォーム市場規模は2023年に3,230万米ドルとなり、2024年から2032年にかけてCAGR 10.90%で拡大

シングルドメイン抗体プラットフォーム市場-市場力学

標的治療への需要の高まりと慢性疾患の有病率の上昇が市場需要を促進すると予測

シングルドメイン抗体プラットフォーム市場は、特にがん領域における標的治療と精密医療の重視の高まりによって牽引されています。抗体は強い親和性と特異性を持つため、オーダーメイドの治療を行うのに最適です。免疫療法、特にがん治療の発展により、免疫反応を制御し腫瘍細胞を特異的に標的とするsdAbsの可能性が注目されています。これらの要因により、市場の拡大が加速すると予想されます。

世界的にがんの罹患率は上昇しており、sdAbsのような新規で効率的な治療に対するニーズは高いです。乾癬、関節リウマチ、その他の慢性疾患のような炎症性疾患の有病率の増加は、新規治療アプローチの必要性を強調しています。カプラシズマブが血栓性血小板減少性紫斑病（TTP）の治療薬として承認されたことは、sdAbに基づく治療法の一例であり、その臨床的可能性を検証し、追加投資に拍車をかけた。炎症性疾患、ウイルス性疾患、自己免疫疾患など多くの疾患が、一本鎖抗体（sdAbs）の潜在的治療法として研究されています。

シングルドメイン抗体プラットフォーム市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約10.90%のCAGRで毎年成長すると予測されています。

市場セグメンテーションに基づくと、多特異的シングルドメイン抗体セグメントは、多特異的抗体に対する診断用途からの高い需要により、2023年に最大の市場シェアを示すと予測されました。

用途別セグメントでは、体外診断用途のニーズが高いことから、診断開発分野が2023年の主要用途でした。

エンドユーザー別では、新薬開発の需要が高いことから、研究開発分野が2023年の主要エンドユーザーでした。

地域別では、北米が2023年に収益でリードし、これは高度なヘルスケアインフラの存在によるものです。

シングルドメイン抗体プラットフォーム市場-セグメンテーション分析：

シングルドメイン抗体プラットフォームの世界市場は、プラットフォームタイプ、アプリケーション、エンドユーザー、地域に基づいてセグメント化されます。

シングルドメイン抗体プラットフォーム市場は、プラットフォームタイプにより、多特異的シングルドメイン抗体、二重特異的シングルドメイン抗体、多価シングルドメイン抗体、単特異的シングルドメイン抗体の4つに分類されます。多特異的シングルドメイン抗体セグメントが市場を独占しています。診断薬開発の増加と複数のニーズがこのセグメントの成長を押し上げると予想されます。

市場は用途別に診断開発、治療開発、研究開発の3つに分類されます。市場を独占しているのは研究開発分野です。政府支援に加え、複数の企業によるR&D開発の増加が市場成長に拍車をかけています。

市場はエンドユーザー別に、診断ラボ、臨床ラボ、学術・研究、製薬・バイオテクノロジー企業、その他の5つに分類されます。診断ラボセグメントは市場を独占しており、予測期間中も高い優位性を維持すると予想されます。学術・研究セグメントは、予測期間中にかなりの速度で拡大すると予測されています。

シングルドメイン抗体プラットフォーム市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。北米が世界市場を独占しています。成長の原動力となっているのは、医薬品治療の進歩と研究開発投資の増加です。USFDAは、新薬開発と研究所の研究活動を積極的に支援しており、これが地域の成長を後押ししています。

シングルドメイン抗体プラットフォーム市場-競合情勢：

シングルドメインアンチボディプラットフォーム市場は競争が激しく、市場参入企業は激しい競争に直面しています。さらに、世界市場の大手企業は、市場での存在感を高めるために、新製品開拓、提携などの戦略的イニシアティブ、投資に注力しています。このような戦略的取り組みには製品の革新も含まれ、各社の市場での存在感を高めるのに役立っています。シングルドメイン抗体プラットフォーム市場の主要企業には、GenScript、Creative BioLabs、Hybrigenics Servicesなどが含まれます。

目次

第1章 シングルドメイン抗体プラットフォーム市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 シングルドメイン抗体プラットフォームの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 シングルドメイン抗体プラットフォーム産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 シングルドメイン抗体プラットフォーム市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 シングルドメイン抗体プラットフォーム市場情勢

  • シングルドメイン抗体プラットフォーム市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 シングルドメイン抗体プラットフォーム市場：プラットフォームタイプ別

  • 概要
    • プラットフォームタイプ別セグメントシェア分析
    • 多特異性シングルドメイン抗体
    • 二重特異性シングルドメイン抗体
    • 多価シングルドメイン抗体
    • 単一特異性シングルドメイン抗体

第8章 シングルドメイン抗体プラットフォーム市場：用途別

  • 概要
    • 用途別セグメントシェア分析
    • 診断開発
    • 治療法の開発
    • 研究開発活動。

第9章 シングルドメイン抗体プラットフォーム市場：エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 診断ラボ
    • 臨床ラボ
    • 学術と研究
    • 製薬・バイオテクノロジー企業
    • その他

第10章 シングルドメイン抗体プラットフォーム市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- シングルドメイン抗体プラットフォーム業界

  • 競合ダッシュボード
  • 企業プロファイル
    • GenScript
    • Creative BioLabs
    • Synbio Technologies
    • ProSci Incorporated
    • BioCat GmbH
    • Hybrigenics Services
    • ProteoGenix
    • Oak BioSciences, Inc.
    • Rockland Immunochemicals
    • Ligand Pharmaceuticals
    • Sanofi
    • Inhibrx, Inc.
    • Kane Biotech Inc.
    • Nomad Bioscience GmbH
    • Novozymes
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Single Domain Antibody Platforms Market: Platform Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Platform Type
  • TABLE Global Single Domain Antibody Platforms Market, by Platform Type 2019-2032 (USD Million)
  • TABLE Single Domain Antibody Platforms Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Single Domain Antibody Platforms Market, by Application 2019-2032 (USD Million)
  • TABLE Single Domain Antibody Platforms Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Single Domain Antibody Platforms Market, by End User 2019-2032 (USD Million)
  • TABLE Single Domain Antibody Platforms Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Single Domain Antibody Platforms Market, by Region 2019-2032 (USD Million)
  • TABLE North America Single Domain Antibody Platforms Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Single Domain Antibody Platforms Market, by Platform Type, 2019-2032 (USD Million)
  • TABLE North America Single Domain Antibody Platforms Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Single Domain Antibody Platforms Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Single Domain Antibody Platforms Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Single Domain Antibody Platforms Market, by Platform Type, 2019-2032 (USD Million)
  • TABLE Europe Single Domain Antibody Platforms Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Single Domain Antibody Platforms Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Single Domain Antibody Platforms Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Single Domain Antibody Platforms Market, by Platform Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Single Domain Antibody Platforms Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Single Domain Antibody Platforms Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Single Domain Antibody Platforms Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Single Domain Antibody Platforms Market, by Platform Type, 2019-2032 (USD Million)
  • TABLE Latin America Single Domain Antibody Platforms Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Single Domain Antibody Platforms Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Single Domain Antibody Platforms Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Single Domain Antibody Platforms Market, by Platform Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Single Domain Antibody Platforms Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Single Domain Antibody Platforms Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2919

REPORT HIGHLIGHT

Single Domain Antibody Platforms Market size was valued at USD 32.30 Million in 2023, expanding at a CAGR of 10.90% from 2024 to 2032.

The technologies and procedures used to produce and employ single domain antibodies (sdAbs), sometimes referred to as nanobodies, are referred to as single domain antibody platforms. These are a particular kind of antibody fragment that is substantially smaller than full-sized antibodies and are composed of a single monomeric variable antibody domain that can selectively bind to a particular antigen.

Single Domain Antibody Platforms Market- Market Dynamics

Growing demand for targeted therapy and the rising prevalence of chronic disorders are expected to propel market demand

The market for single-domain antibody platforms is driven by the growing emphasis on targeted medicines and precision medicine, particularly in oncology. They are perfect for creating tailored treatments because of their strong affinity and specificity. Developments in immunotherapy, especially in the treatment of cancer, have brought attention to the potential of sdAbs in regulating immune responses and specifically targeting tumor cells. These factors are anticipated to accelerate market expansion.

Globally, cancer prevalence is rising, which means there is a big need for novel, efficient treatments like sdAbs. The increasing prevalence of inflammatory disorders like psoriasis, rheumatoid arthritis, and other chronic diseases emphasizes the need for novel treatment approaches. Caplacizumab's regulatory approval for treating thrombotic thrombocytopenic purpura (TTP) is one example of a sdAb-based treatment that validates its clinical potential and spurs additional investment. Many ailments, such as inflammatory, viral, and autoimmune disorders, are being investigated as potential treatments for single-strand antibodies (sdAbs).

Single Domain Antibody Platforms Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.90% over the forecast period (2024-2032)

Based on Platform Type segmentation, the multispecific single domain antibody segment was predicted to show maximum market share in 2023, owing to high demand from diagnostic applications for multi-specific antibodies.

Based on Application segmentation, the diagnostic development segment was the leading Application in 2023, due to the high need for applications in vitro diagnostics.

Based on End User segmentation, the research & development activities segment was the leading End User in 2023, owing to high demand from novel drug development.

On the basis of region, North America was the leading revenue generator in 2023, owing to the presence of advanced healthcare infrastructure.

Single Domain Antibody Platforms Market- Segmentation Analysis:

The Global Single Domain Antibody Platforms Market is segmented on the basis of Platform Type, Application, End User, and Region.

The market is divided into four categories based on Platform Type: multi-specific single-domain antibody, bispecific single-domain antibody, multivalent single-domain antibody, and mono-specific single-domain antibody. The multi-specific single-domain antibody segment dominates the market. Increasing diagnostic development and multiple needs are expected to boost the segment growth.

The market is divided into three categories based on Application: diagnostic development, therapeutic development, and research & development activities. The research & development segment dominates the market. The increasing number of R&D developments by several companies along with government support is spurring the market growth.

The market is divided into five categories based on End Users: diagnostic laboratories, clinical laboratories, academics & research, pharma & biotech companies, and others. The diagnostic laboratories segment dominates the market and is expected to maintain its high dominance during the forecast period. The academic & research segment is anticipated to expand at a significant rate over the forecast period.

Single Domain Antibody Platforms Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the global market. The growth is driven by advancements in pharmaceutical therapies and increased R&D investments. The USFDA has positively supported the new drug development and laboratory research activities, which, in turn is booting the regional growth.

Single Domain Antibody Platforms Market- Competitive Landscape:

The Single Domain Antibody Platforms market is highly competitive in nature with market players facing intense competition. Further, large players in the global market focus on new product development, strategic initiatives like collaboration, and investment to increase their market presence. These strategic initiatives include product innovation, helping the companies to increase their market presence. Key companies in the Single Domain Antibody Platforms Market include GenScript, Creative BioLabs, and Hybrigenics Services, etc.

Recent Developments:

In the 2023 Antibody Engineering & Therapeutics Conference, held in Sand Diego, OmniAb Inc., presented new scientific data on OmnidAb platform that produces single domain antibodies.

In 2022, GenScript Biotech Corporation completed an agreement with Ligand Pharmaceuticals for OmniAb Platform.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SINGLE DOMAIN ANTIBODY PLATFORMS MARKET KEY PLAYERS

  • GenScript
  • Creative BioLabs
  • Synbio Technologies
  • ProSci Incorporated
  • BioCat GmbH
  • Hybrigenics Services
  • ProteoGenix
  • Oak BioSciences, Inc.
  • Rockland Immunochemicals
  • Ligand Pharmaceuticals
  • Sanofi
  • Inhibrx, Inc.
  • Kane Biotech Inc.
  • Nomad Bioscience GmbH
  • Novozymes
  • Others

GLOBAL SINGLE DOMAIN ANTIBODY PLATFORMS MARKET, BY PLATFORM TYPE- MARKET ANALYSIS, 2019-2032

  • Multi specific single-domain antibody
  • Bispecific single-domain antibody
  • Multivalent single-domain antibody
  • Mono-specific single-domain antibody

GLOBAL SINGLE DOMAIN ANTIBODY PLATFORMS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Diagnostic development
  • Therapeutic development
  • Research & development activities

GLOBAL SINGLE DOMAIN ANTIBODY PLATFORMS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Diagnostic laboratories
  • Clinical laboratories
  • Academics & research
  • Pharma & biotech companies
  • Others

GLOBAL SINGLE DOMAIN ANTIBODY PLATFORMS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Single Domain Antibody Platforms Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Single Domain Antibody Platforms Market Snippet by Platform Type
    • 2.1.2. Single Domain Antibody Platforms Market Snippet by Application
    • 2.1.3. Single Domain Antibody Platforms Market Snippet by End User
    • 2.1.4. Single Domain Antibody Platforms Market Snippet by Country
    • 2.1.5. Single Domain Antibody Platforms Market Snippet by Region
  • 2.2. Competitive Insights

3. Single Domain Antibody Platforms Key Market Trends

  • 3.1. Single Domain Antibody Platforms Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Single Domain Antibody Platforms Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Single Domain Antibody Platforms Market Opportunities
  • 3.4. Single Domain Antibody Platforms Market Future Trends

4. Single Domain Antibody Platforms Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Single Domain Antibody Platforms Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Single Domain Antibody Platforms Market Landscape

  • 6.1. Single Domain Antibody Platforms Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Single Domain Antibody Platforms Market - By Platform Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Platform Type, 2024 & 2032 (%)
    • 7.1.2. Multi specific single-domain antibody
    • 7.1.3. Bispecific single-domain antibody
    • 7.1.4. Multivalent single-domain antibody
    • 7.1.5. Mono-specific single-domain antibody

8. Single Domain Antibody Platforms Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Diagnostic development
    • 8.1.3. Therapeutic development
    • 8.1.4. Research & development Activities.

9. Single Domain Antibody Platforms Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Diagnostic laboratories
    • 9.1.3. Clinical laboratories
    • 9.1.4. Academics & research
    • 9.1.5. Pharma & biotech companies
    • 9.1.6. Others

10. Single Domain Antibody Platforms Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Single Domain Antibody Platforms Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Single Domain Antibody Platforms Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Single Domain Antibody Platforms Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Single Domain Antibody Platforms Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Single Domain Antibody Platforms Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Single Domain Antibody Platforms Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GenScript
    • 11.2.2. Creative BioLabs
    • 11.2.3. Synbio Technologies
    • 11.2.4. ProSci Incorporated
    • 11.2.5. BioCat GmbH
    • 11.2.6. Hybrigenics Services
    • 11.2.7. ProteoGenix
    • 11.2.8. Oak BioSciences, Inc.
    • 11.2.9. Rockland Immunochemicals
    • 11.2.10. Ligand Pharmaceuticals
    • 11.2.11. Sanofi
    • 11.2.12. Inhibrx, Inc.
    • 11.2.13. Kane Biotech Inc.
    • 11.2.14. Nomad Bioscience GmbH
    • 11.2.15. Novozymes
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us